Can chills contribute to elevated Creatine Kinase (CK) levels in a psychiatric patient on antipsychotic medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Chills Cause Elevated CK in Psychiatric Patients on Antipsychotics?

No, chills alone do not directly cause elevated creatine kinase (CK) levels, but they may be an early warning sign of neuroleptic malignant syndrome (NMS) or represent autonomic instability that accompanies the muscle rigidity and breakdown that does elevate CK.

Understanding the Relationship Between Chills and CK Elevation

Chills in a psychiatric patient on antipsychotics should raise immediate concern for NMS, where autonomic dysfunction (including diaphoresis, temperature dysregulation, and subjective chills) often appears before other cardinal symptoms develop. 1

The actual mechanism of CK elevation involves:

  • Muscle rigidity and sustained contraction from dopamine D2 receptor blockade in nigrostriatal pathways, which causes increased calcium release from the sarcoplasmic reticulum, leading to muscle cell breakdown (rhabdomyolysis) and CK release into the bloodstream 1, 2
  • Hyperthermia from hypothalamic D2 receptor blockade, which increases the temperature set point and impairs heat-dissipating mechanisms, further contributing to muscle damage 1, 2
  • Sustained muscle contractility in the periphery that generates both rigidity and excessive heat production, worsening the cycle of muscle breakdown 1

Critical Diagnostic Algorithm

When encountering a psychiatric patient on antipsychotics with chills and elevated CK, immediately assess for:

Cardinal NMS features: 1, 2

  • Hyperthermia (temperature >38°C or 100.4°F)
  • Lead-pipe muscle rigidity (not just stiffness)
  • Altered mental status (ranging from confusion to stupor)
  • Autonomic instability (tachycardia, blood pressure fluctuations, diaphoresis, pallor)

Laboratory confirmation: 1, 2

  • CK elevation ≥4 times upper limit of normal (often 1,000-10,000 U/L in NMS)
  • Leukocytosis (15,000-30,000 cells/mm³)
  • Metabolic acidosis on arterial blood gas
  • Myoglobinuria if rhabdomyolysis is severe

Alternative Causes of CK Elevation to Exclude

Before attributing elevated CK solely to chills or early NMS, rule out: 3, 4, 5

  • Intramuscular injections (very common in psychiatric settings)
  • Physical restraints or intense isometric activity
  • Acute dystonic reactions from antipsychotics
  • Massive asymptomatic CK elevation (MACKE), which can occur with antipsychotics (clozapine, risperidone, olanzapine, haloperidol) without NMS features, reaching levels of 1,206-177,363 IU/L 6, 4
  • Cardiac causes (acute coronary syndrome)
  • Alcohol use or withdrawal

Critical Management Decisions

If chills are accompanied by ANY NMS features (fever, rigidity, altered mental status): 1, 2

  • Immediately discontinue all antipsychotic medications
  • Initiate aggressive IV hydration to prevent renal failure from rhabdomyolysis
  • Implement external cooling measures for hyperthermia
  • Use benzodiazepines as first-line agents for agitation (not additional antipsychotics)
  • Monitor CK, renal function, and electrolytes closely

If CK is massively elevated (>10,000 U/L) but patient is asymptomatic: 6, 4

  • This may represent MACKE rather than NMS
  • Weekly CK monitoring is only necessary if there are signs of toxicity or harm
  • Continue antipsychotic cautiously with close observation for flu-like symptoms, fever, weakness, muscle rigidity, dark urine, or altered consciousness
  • MACKE is often self-limiting (4-28 days) and may not require drug discontinuation 4

If only chills are present without other NMS features: 3, 5

  • Obtain baseline CK, CBC, comprehensive metabolic panel, and urinalysis
  • Carefully monitor for development of rigidity, fever, or mental status changes over the next 24-48 hours
  • Consider that chills may represent early autonomic dysfunction preceding full NMS

Common Pitfalls to Avoid

  • Do not wait for all four cardinal NMS features to be present before acting—autonomic dysfunction (including chills) may precede other symptoms by hours to days 1
  • Do not assume all CK elevations in psychiatric patients represent NMS—MACKE can occur without any clinical syndrome and may resolve spontaneously even with continued antipsychotic treatment 6, 4
  • Do not routinely monitor CK in asymptomatic patients on antipsychotics, but maintain high vigilance when muscular symptoms or autonomic changes develop 3, 4
  • Do not rechallenge with the same antipsychotic after confirmed NMS without careful consideration, though rechallenge after MACKE may be safer 3, 6

Key Distinction: NMS vs. MACKE

The presence or absence of clinical symptoms distinguishes these entities: 6, 4

  • NMS: Symptomatic with fever, rigidity, altered mental status, autonomic instability; CK typically 500-10,000 U/L; requires immediate drug discontinuation
  • MACKE: Asymptomatic or minimal flu-like symptoms; CK can exceed 100,000 U/L; often self-limiting; may not require drug discontinuation

The bottom line: Chills themselves do not elevate CK, but they may herald the autonomic dysfunction and muscle rigidity that do cause CK elevation in NMS. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Neuroleptic Malignant Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1996

Research

[Importance of creatine kinase psychiatry--truths and myths].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.